Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Sanofi
|
| gptkbp:acquisitionYear |
2020
|
| gptkbp:focusesOn |
oncology
autoimmune diseases |
| gptkbp:foundedYear |
2008
|
| gptkbp:headquartersLocation |
gptkb:San_Francisco,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Principia Biopharma
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:PRN1008
gptkb:PRN1371 |
| gptkbp:stockSymbol |
gptkb:PRNB
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:website |
https://www.principiabio.com/
|
| gptkbp:bfsParent |
gptkb:Sofinnova_Investments
|
| gptkbp:bfsLayer |
6
|